FDA announces agreement in principle on medical device user fees

On Feb. 1, The U.S. Food and Drug Administration (FDA) and medical device industry representatives announced they had reached an agreement in principle on proposed recommendations for the reauthorization of a medical device user fee program. The recommendations would authorize the FDA to collect $595 million in user fees over five years, plus adjustments for inflation. Read more.


Please enter your comment!
Please enter your name here